Figure 4 | Scientific Reports

Figure 4

From: Association of Arachidonic Acid-derived Lipid Mediators with Subsequent Onset of Acute Myocardial Infarction in Patients with Coronary Artery Disease

Figure 4

Kaplan–Meier curves of outcomes associated with specific cytochrome P450s (CYPs) catalyzed arachidonic acid metabolites in patients with coronary artery disease. The rates of freedom from acute myocardial infarction are shown: (A) 19-HETE ≥ 6.03 ng/mL vs.19-HETE < 6.03 ng/mL; (B) 20-HETE ≥ 11.34 ng/mL vs. 20-HETE < 11.34 ng/mL; (C) 5,6-EET ≥ 34.42 ng/mL vs. 5,6-EET < 34.42 ng/mL; (D) 8,9-EET ≥ 24.50 ng/mL vs. 8,9-EET < 24.50 ng/mL; (E) 11,12-EET ≥ 74.26 ng/mL vs. 11,12-EET < 74.26 ng/mL; (F) 14,15-EET ≥ 44.53 ng/mL vs. 14,15-EET < 44.53 ng/mL.

Back to article page